<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="147991">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01912287</url>
  </required_header>
  <id_info>
    <org_study_id>2013P000048</org_study_id>
    <secondary_id>1R01AT007258-01A1</secondary_id>
    <nct_id>NCT01912287</nct_id>
  </id_info>
  <brief_title>GATE: Generalized Anxiety - A Treatment Evaluation</brief_title>
  <official_title>GATE: Generalized Anxiety - A Treatment Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Alternative Medicine (NCCAM)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized study is to examine the comparative efficacy of yoga,
      cognitive behavioral therapy, and stress education, a previously employed control condition,
      for patients with Generalized Anxiety Disorder.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Treatment Response as Assessed by the Clinical Global Impression-Improvement (CGI-I of 1 or 2) scale</measure>
    <time_frame>Biweekly from weeks 0 through 12, and 6-month follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A)</measure>
    <time_frame>Weeks 0, 6 , 12 and 6 month follow up</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Generalized Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>Yoga</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 week session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy (CBT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 week session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stress Education</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>12 week session</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <arm_group_label>Cognitive Behavioral Therapy (CBT)</arm_group_label>
    <other_name>CBT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stress Education</intervention_name>
    <arm_group_label>Stress Education</arm_group_label>
    <other_name>SE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Yoga</intervention_name>
    <arm_group_label>Yoga</arm_group_label>
    <other_name>Kundalini Yoga</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female outpatients &gt; 18 years of age with a primary psychiatric diagnosis of
             generalized anxiety disorder

          -  Clinical Global Impression-Severity scale (CGI-S) score of 4 or higher

          -  Off concurrent psychotropic medication for at least 2 weeks prior to initiation of
             randomized treatment, OR stable on current medication for a minimum of 6 weeks and
             willing to maintain a stable dose

          -  Willingness and ability to perform the yoga intervention and to comply with the
             requirements of the study protocol.

          -  For women of childbearing potential, willingness to use a reliable form of birth
             control

        Exclusion Criteria:

          -  Patients unable to understand study procedures and participate in the informed
             consent process.

          -  Pregnancy as assessed by pregnancy test at screen or lack of use approved methods
             birth control for women of childbearing age

          -  Women who are planning to become pregnant

          -  Serious medical illness or instability for which hospitalization may be likely within
             the next year

          -  Significant current suicidal ideation or suicidal behaviors within the past 6 months
             (assessed with the Beck Depression Inventory-II [BDI-II])

          -  History of head trauma causing loss of consciousness, or seizure disorder resulting
             in ongoing cognitive impairment

          -  Posttraumatic stress disorder, substance use disorder, eating disorder, or organic
             mental disorder within the past 6 months

          -  Lifetime history of psychotic disorder, bipolar disorder, or developmental disorder

          -  Significant personality dysfunction likely to interfere with study participation
             (assessed during the clinical interview)

          -  Prior experience with (more than 5 Yoga classes or CBT sessions within the last 3
             years) and/or current practice of mindbody techniques (e.g., yoga, meditation,
             Tai-Chi, etc) or cognitive behavioral therapy (CBT)

          -  Concomitant therapy for generalized anxiety disorder (GAD) (any therapy)

          -  Physical conditions that might cause injury from yoga (pregnancy, physical injuries
             and musculoskeletal problems)

          -  Cognitive impairment (MOCA&lt;21)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naomi M Simon, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan G Hofmann, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Campbell</last_name>
      <phone>617-726-3508</phone>
      <email>acampbell7@partners.org</email>
    </contact>
    <investigator>
      <last_name>Naomi M Simon, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelley Kind</last_name>
      <phone>617-353-9610</phone>
      <email>slkind@bu.edu</email>
    </contact>
    <investigator>
      <last_name>Stefan G Hofmann, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 16, 2014</lastchanged_date>
  <firstreceived_date>July 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Naomi M. Simon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Generalized Anxiety Disorder</keyword>
  <keyword>GAD</keyword>
  <keyword>Yoga</keyword>
  <keyword>CBT</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
